Zeo ScientifiX, Inc.

ZEOX OTC CIK: 0001557376

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 3321 COLLEGE AVENUE, DAVIE, FL, 33314
Mailing Address 3321 COLLEGE AVENUE, DAVIE, FL, 33314
Phone 888-963-7881
Fiscal Year End 1031
EIN 474180540

Financial Overview

FY2024

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13D/A Beneficial ownership amendment February 6, 2026 View on SEC
3 Initial insider ownership report February 6, 2026 View on SEC
10-K Annual financial report January 29, 2026 View on SEC
8-K Current report of material events January 28, 2026 View on SEC
8-K Current report of material events January 21, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
8-K Current report of material events January 7, 2026 View on SEC
8-K Current report of material events January 5, 2026 View on SEC

Annual Reports

10-K January 29, 2026
  • Clinical-stage biopharmaceutical company focused on innovative biological treatments for degenerative diseases and regenerative medicine.
  • Develops products from ethically sourced birth tissue, including two main candidates: Zofin™ and Patient Pure X™ (PPX™).
View Analysis

Material Events

8-K Leadership Change January 5, 2026
Medium Impact
  • Ian T. Bothwell has been officially appointed as the full-time Chief Executive Officer (CEO) of Zeo ScientifiX, Inc.
  • Bothwell will continue to serve in his existing role as Chief Financial Officer (CFO), holding both key positions.
View Analysis

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.